相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Enzymes involved in tumor-driven angiogenesis: A valuable target for anticancer therapy
Biagio Ricciuti et al.
SEMINARS IN CANCER BIOLOGY (2019)
Pro- and antiangiogenic therapies: current status and clinical implications
Ruslan Rust et al.
FASEB JOURNAL (2019)
The Role of Fibrinolytic Regulators in Vascular Dysfunction of Systemic Sclerosis
Yosuke Kanno
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Angiogenesis in Pancreatic Cancer: Pre-Clinical and Clinical Studies
Tiziana Annese et al.
CANCERS (2019)
Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatment
Ming Yi et al.
MOLECULAR CANCER (2019)
Antitumor effects of Endostar(rh-endostatin) combined with gemcitabine in different administration sequences to treat Lewis lung carcinoma
Yuan Li et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Antiangiogenic properties of nanoparticles: a systematic review
Brhaish Ali Saeed et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Heterogeneity of Vascular Endothelial Cells, De Novo Arteriogenesis and Therapeutic Implications in Pancreatic Neuroendocrine Tumors
Bin Ren et al.
JOURNAL OF CLINICAL MEDICINE (2019)
The Role of Angiogenesis and Pro-Angiogenic Exosomes in Regenerative Dentistry
Alina-Andreea Zimta et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Tumor microenvironment: Interactions and therapy
Masoud Najafi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Therapeutic angiogenesis: From conventional approaches to recent nanotechnology-based interventions
Robin Augustine et al.
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2019)
Beyond endothelial cells: Vascular endothelial growth factors in heart, vascular anomalies and placenta
Johanna P. Laakkonen et al.
VASCULAR PHARMACOLOGY (2019)
Efficacy and toxicities of gemcitabine and cisplatin combined with endostar in advanced thymoma and thymic carcinoma
Yang Wang et al.
THORACIC CANCER (2019)
Resistance to chemotherapy and anti-angiogenic therapy in ovarian cancer
Verena Wieser et al.
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY (2019)
Capillary dynamics, interstitial fluid and the lymphatic system
Andrew Haggerty et al.
ANAESTHESIA AND INTENSIVE CARE MEDICINE (2019)
Angiogenic factors: role in esophageal cancer, a brief review
Katia Ladeira et al.
ESOPHAGUS (2018)
Aptamer-based biosensors and nanosensors for the detection of vascular endothelial growth factor (VEGF): A review
Sadegh Dehghani et al.
BIOSENSORS & BIOELECTRONICS (2018)
Angiogenesis in peripheral arterial disease
Chakradhari Inampudi et al.
CURRENT OPINION IN PHARMACOLOGY (2018)
VEGF (Vascular Endothelial Growth Factor) and Fibrotic Lung Disease
Shaney L. Barratt et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Positive and Negative Regulation of Angiogenesis by Soluble Vascular Endothelial Growth Factor Receptor-1
Cristina M. Failla et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Endogenous Antiangiogenic Factors in Chronic Kidney Disease: Potential Biomarkers of Progression
Katsuyuki Tanabe et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Immunohistochemical evaluation of tumor angiogenesis and the role of mast cells in oral squamous cell carcinoma
Arpita Kabiraj et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2018)
Important signals regulating coronary artery angiogenesis
Sara Shoeibi et al.
MICROVASCULAR RESEARCH (2018)
Platelet-derived growth factor-C and -D in the cardiovascular system and diseases
Chunsik Lee et al.
MOLECULAR ASPECTS OF MEDICINE (2018)
Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
Dal Fukurnura et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa
Kabir A. Khan et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Nanotherapeutic approaches targeting angiogenesis and immune dysfunction in tumor microenvironment
Sadaf Hameed et al.
SCIENCE CHINA-LIFE SCIENCES (2018)
Delayed recognition of Judah Folkman's hypothesis on tumor angiogenesis: when a Prince awakens a Sleeping Beauty by self-citation
Adil El Aichouchi et al.
SCIENTOMETRICS (2018)
Tumor angiogenesis and anti-angiogenic gene therapy for cancer (Review)
Tinglu Li et al.
ONCOLOGY LETTERS (2018)
Current Challenges of Cancer Anti-angiogenic Therapy and the Promise of Nanotherapeutics
Ahmed M. E. Abdalla et al.
THERANOSTICS (2018)
Tumor Angiogenesis: A Key Target for Cancer Therapy
Dieter Marme
ONCOLOGY RESEARCH AND TREATMENT (2018)
Anti-Angiogenics: Current Situation and Future Perspectives
Katja Zirlik et al.
ONCOLOGY RESEARCH AND TREATMENT (2018)
Modelling skin wound healing angiogenesis: A review
Ana Guerra et al.
JOURNAL OF THEORETICAL BIOLOGY (2018)
Apatinib combined with oral etoposide in patients with platinum-resistant or platinum-refractory ovarian cancer (AEROC): a phase 2, single-arm, prospective study
Chun-Yan Lan et al.
LANCET ONCOLOGY (2018)
Recent advances in anti-angiogenic nanomedicines for cancer therapy
Pravin Bhattarai et al.
NANOSCALE (2018)
Enhanced antitumor and anti-angiogenic effects of metronomic Vinorelbine combined with Endostar on Lewis lung carcinoma
Rong-Sheng Qin et al.
BMC CANCER (2018)
Targeting VEGF pathway to normalize the vasculature: an emerging insight in cancer therapy
Jing-biao Wu et al.
ONCOTARGETS AND THERAPY (2018)
Monitoring of tumor vascular normalization: the key points from basic research to clinical application
Wei Li et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Molecular Regulation of Sprouting Angiogenesis
Camille L. Duran et al.
COMPREHENSIVE PHYSIOLOGY (2018)
Emerging Roles for VEGF-D in Human Disease
Steven A. Stacker et al.
BIOMOLECULES (2018)
Effects of vascular endothelial growth factors and their receptors on megakaryocytes and platelets and related diseases
Jin-Gang Yang et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Biology of Vascular Endothelial Growth Factor C in the Morphogenesis of Lymphatic Vessels
Khushbu Rauniyar et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2018)
Vasculogenesis and Its Cellular Therapeutic Applications
Anna Ratajska et al.
CELLS TISSUES ORGANS (2017)
Angiogenic growth factors in myocardial infarction: a critical appraisal
Hemalatha Thiagarajan et al.
HEART FAILURE REVIEWS (2017)
Biological Pathways Involved in Tumor Angiogenesis and Bevacizumab Based Anti-Angiogenic Therapy with Special References to Ovarian Cancer
Vera Loizzi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Platelet Factor 4 Binds to Vascular Proteoglycans and Controls Both Growth Factor Activities and Platelet Activation
Megan S. Lord et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Acquired tumor resistance to antiangiogenic therapy: Mechanisms at a glance
Bahare Zarrin et al.
JOURNAL OF RESEARCH IN MEDICAL SCIENCES (2017)
The Angiopoietin-Tie2 Signaling Axis in Systemic Inflammation
Samir M. Parikh
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Combining Anti-Angiogenesis and Immunotherapy Enhances Antitumor Effect by Promoting Immune Response in Lung Cancer
Sha Zhao et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
The Potential of Combined Immunotherapy and Antiangiogenesis for the Synergistic Treatment of Advanced NSCLC
Christian Manegold et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
The Role of PDGFs and PDGFRs in Colorectal Cancer
RobertaM. Manzat Saplacan et al.
MEDIATORS OF INFLAMMATION (2017)
Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming
Lin Tian et al.
NATURE (2017)
Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation
Elizabeth Allen et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Molecular regulation and role of angiogenesis in reproduction
Momchil Rizov et al.
TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY (2017)
Cross-talk mechanism between endothelial cells and hepatocellular carcinoma cells via growth factors and integrin pathway promotes tumor angiogenesis and cell migration
Tang Feng et al.
ONCOTARGET (2017)
Endostar in combination with postoperative adjuvant chemotherapy prolongs the disease free survival of stage IIIA NSCLC patients with high VEGF expression
Zhiwei Chen et al.
ONCOTARGET (2017)
Quantifying the effects of antiangiogenic and chemotherapy drug combinations on drug delivery and treatment efficacy
Sirin Yonucu et al.
PLOS COMPUTATIONAL BIOLOGY (2017)
Gastrointestinal cancer cells treatment with bevacizumab activates a VEGF autoregulatory mechanism involving telomerase catalytic subunit hTERT via PI3K-AKT, HIF-1α and VEGF receptors
Nadine Mahfouz et al.
PLOS ONE (2017)
An overview of the role of platelets in angiogenesis, apoptosis and autophagy in chronic myeloid leukaemia
Lisa Repsold et al.
CANCER CELL INTERNATIONAL (2017)
Microenvironmental regulation of tumour angiogenesis
Michele de Palma et al.
NATURE REVIEWS CANCER (2017)
A chemotherapy combined with an anti-angiogenic drug applied to a cancer model including angiogenesis
Christophe Letellier et al.
CHAOS SOLITONS & FRACTALS (2017)
Platelets and cancer angiogenesis nexus
Marek Z. Wojtukiewicz et al.
CANCER AND METASTASIS REVIEWS (2017)
The Role of Angiogenesis in Cancer Treatment
Mehdi Rajabi et al.
BIOMEDICINES (2017)
Hepatocyte growth factor (HGF) and hemodialysis: physiopathology and clinical implications
Carmelo Libetta et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2016)
Current therapies and investigational drugs for peripheral arterial disease
Jun-ichi Suzuki et al.
HYPERTENSION RESEARCH (2016)
Targeting hypoxia-inducible factor 1 to stimulate tissue vascularization
Gregg L. Semenza
JOURNAL OF INVESTIGATIVE MEDICINE (2016)
Endostatin and endorepellin: A common route of action for similar angiostatic cancer avengers
Chiara Poluzzi et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Commentary on Folkman: Tumor Angiogenesis Factor
Rebecca G. Bagley
CANCER RESEARCH (2016)
Therapeutic angiogenesis by vascular endothelial growth factor supplementation for treatment of renal disease
Omar C. Logue et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2016)
Angiopoietins and diabetic nephropathy
Luigi Gnudi
DIABETOLOGIA (2016)
Therapeutic application of anti-angiogenic nanomaterials in cancers
Sudip Mukherjee et al.
NANOSCALE (2016)
Vascular endothelial growth factor and diabetic macular edema
David R. Lally et al.
SURVEY OF OPHTHALMOLOGY (2016)
Vascularization and Angiogenesis in Tissue Engineering: Beyond Creating Static Networks
Jeroen Rouwkema et al.
TRENDS IN BIOTECHNOLOGY (2016)
The VEGF rise in blood of bevacizumab patients is not based on tumor escape but a host-blockade of VEGF clearance
Lejla Alidzanovic et al.
ONCOTARGET (2016)
Angiopoietin-1 and Angiopoietin-2 in metabolic disorders: therapeutic strategies to restore the highs and lows of angiogenesis in diabetes
A. M. Isidori et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2016)
Therapeutic angiogenesis: angiogenic growth factors for ischemic heart disease
Robert J. Henning
FUTURE CARDIOLOGY (2016)
Final overall survival and safety analysis of OCEANS, a phase 3 trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent ovarian cancer
Carol Aghajanian et al.
GYNECOLOGIC ONCOLOGY (2015)
Hypoxia-Inducible Factor-1 in Physiological and Pathophysiological Angiogenesis: Applications and Therapies
Agnieszka Zimna et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Hypoxia-inducible factor as an angiogenic master switch
Takuya Hashimoto et al.
FRONTIERS IN PEDIATRICS (2015)
The Great Escape; the Hallmarks of Resistance to Antiangiogenic Therapy
Judy R. van Beijnum et al.
PHARMACOLOGICAL REVIEWS (2015)
Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
Eric Pujade-Lauraine et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
The impact of the immune system on tumor: angiogenesis and vascular remodeling
Christian Stockmann et al.
FRONTIERS IN ONCOLOGY (2014)
Anti-VEGF/VEGFR Therapy for Cancer: Reassessing the Target
Basel Sitohy et al.
CANCER RESEARCH (2012)
The vascular endothelial growth factor (VEGF)-E encoded by orf virus regulates keratinocyte proliferation and migration and promotes epidermal regeneration
Lyn M. Wise et al.
CELLULAR MICROBIOLOGY (2012)
Platelets in Angiogenesis
Johannes Patzelt et al.
CURRENT VASCULAR PHARMACOLOGY (2012)
Molecular Basis for the Regulation of Angiogenesis by Thrombospondin-1 and-2
Patrick R. Lawler et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2-Negative, Locally Recurrent or Metastatic Breast Cancer
Nicholas J. Robert et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer
David W. Miles et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Role of the platelet chemokine platelet factor 4 (PF4) in hemostasis and thrombosis
M. Anna Kowalska et al.
THROMBOSIS RESEARCH (2010)
Independent Review of E2100: A Phase III Trial of Bevacizumab Plus Paclitaxel Versus Paclitaxel in Women With Metastatic Breast Cancer
Robert Gray et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Regulation of tumor angiogenesis by thrombospondin-1
Bin Ren et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2006)
分享论文
